TY - JOUR
T1 - Less is more
T2 - Abdominal closure protocol does not reduce surgical site infection after hysterectomy
AU - DeMari, Joseph A.
AU - Boyles, Glenn P.
AU - Barrington, David A.
AU - Audrey Busho, B. S.
AU - Jae Baek, B. S.
AU - Cohn, David E.
AU - Nagel, Christa I.
N1 - Funding Information:
This paper expands upon the work presented as a poster at the 2022 Winter Society of Gynecologic Oncology meeting.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/7
Y1 - 2022/7
N2 - Objectives: To determine rates of surgical site infection (SSI) with and without an abdominal closure protocol for gynecologic oncology patients undergoing abdominal hysterectomy. Methods: Consecutive patients were identified using CPT codes who underwent total abdominal hysterectomy by gynecologic oncologists at a tertiary care center from January 1, 2015 to December 31, 2019, and stratified by use of the abdominal closure protocol. Demographic, perioperative, and pathologic variables were collected. Fisher's exact and Chi squared tests were used for categorical variables, logistic regression and student t-tests for continuous variables. Multiple logistic regression was used to analyze the relationships between these variables, use of the closure protocol, and development of SSI. Results: 739 patients were included over the study period (n = 393 pre-implementation, n = 346 post-implementation of the abdominal closure protocol,). Baseline demographics including ASA score, BMI, diabetes, and smoking were similar between these groups (P = 0.14–0.94). The rate of SSI within 30 days was 5.9% (23/393) in the pre-protocol group and 8.1% (28/346) under the abdominal closure protocol (P = 0.25). On univariate analysis, factors associated with SSI were BMI >40, diabetes, bowel resection, ASA score 3 or 4, hypertension, and contaminated wound class (uOR 2.31–4.09). On multivariate analysis BMI >40, diabetes, and bowel resection remained independent risk factors (aOR 2.27–2.99), with the closure protocol not achieving significance (aOR 1.43, 95% CI 0.79–2.59). There were no potentially high-risk sub-groups in whom the closing protocol showed benefit. Conclusion: The abdominal closure protocol in isolation did not decrease SSI in those undergoing TAH by a gynecologic oncologist.
AB - Objectives: To determine rates of surgical site infection (SSI) with and without an abdominal closure protocol for gynecologic oncology patients undergoing abdominal hysterectomy. Methods: Consecutive patients were identified using CPT codes who underwent total abdominal hysterectomy by gynecologic oncologists at a tertiary care center from January 1, 2015 to December 31, 2019, and stratified by use of the abdominal closure protocol. Demographic, perioperative, and pathologic variables were collected. Fisher's exact and Chi squared tests were used for categorical variables, logistic regression and student t-tests for continuous variables. Multiple logistic regression was used to analyze the relationships between these variables, use of the closure protocol, and development of SSI. Results: 739 patients were included over the study period (n = 393 pre-implementation, n = 346 post-implementation of the abdominal closure protocol,). Baseline demographics including ASA score, BMI, diabetes, and smoking were similar between these groups (P = 0.14–0.94). The rate of SSI within 30 days was 5.9% (23/393) in the pre-protocol group and 8.1% (28/346) under the abdominal closure protocol (P = 0.25). On univariate analysis, factors associated with SSI were BMI >40, diabetes, bowel resection, ASA score 3 or 4, hypertension, and contaminated wound class (uOR 2.31–4.09). On multivariate analysis BMI >40, diabetes, and bowel resection remained independent risk factors (aOR 2.27–2.99), with the closure protocol not achieving significance (aOR 1.43, 95% CI 0.79–2.59). There were no potentially high-risk sub-groups in whom the closing protocol showed benefit. Conclusion: The abdominal closure protocol in isolation did not decrease SSI in those undergoing TAH by a gynecologic oncologist.
KW - Closing tray
KW - Perioperative outcomes
KW - Surgical bundles
UR - http://www.scopus.com/inward/record.url?scp=85129729376&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2022.04.020
DO - 10.1016/j.ygyno.2022.04.020
M3 - Article
C2 - 35525601
AN - SCOPUS:85129729376
SN - 0090-8258
VL - 166
SP - 69
EP - 75
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 1
ER -